SCHEMBL9296010

SCHEMBL9296010

Cc1ccc(S(=O)(=O)Oc2c[nH]nn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
CYP2C19 P33261 1/20 0.43
P2RY12 Q9H244 1/20 0.42
PPARG P37231 1/20 0.41
GAA P10253 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
MAPT P10636 3/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
HTR6 P50406 1/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746510 0.75 KEAP1 (0.45) KEAP1NFE2L2CYP2C19P2RY12PPARG
SCHEMBL1976807 0.72 GAA (0.52) GAAMEN1KMT2AMAPTMCOLN3
SCHEMBL11282762 0.72 HTR1D (0.32)
SCHEMBL31226026 0.71 ALDH1A1 (0.46) KEAP1NFE2L2CYP2C19P2RY12PPARG
SCHEMBL7838072 0.71 PSMD10 (0.42) KEAP1NFE2L2CYP2C19GAAKMT2A
SCHEMBL9852204 0.70 MEN1 (0.60) CYP2C19PPARGGAAMEN1KMT2A
SCHEMBL18179825 0.70 MEN1 (0.60) CYP2C19PPARGGAAMEN1KMT2A
SCHEMBL4126086 0.70 MEN1 (0.60) CYP2C19PPARGGAAMEN1KMT2A
SCHEMBL3386026 0.70 KEAP1 (0.51) KEAP1NFE2L2CYP2C19P2RY12GAA
SCHEMBL3100559 0.70 KEAP1 (0.51) KEAP1NFE2L2CYP2C19P2RY12GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200317976-A1 NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE MONASH UNIVERSITY (AU) 2020-10-08 US claimed
EP-3458539-A1 NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE Monash University (AU) 2019-03-27 EP claimed
WO-2017197438-A1 NOVEL PHASE CHANGE MATERIAL AND METHODS OF USE MONASH UNIVERSITY (AU) 2017-11-23 WO claimed
US-5326776-A Tetrazoles ABBOTT LABORATORIES (US) 1994-07-05 US disclosed
WO-1993017681-A1 ANGIOTENSIN II RECEPTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1993-09-16 WO disclosed